(Q40620337)

22 September 2017

Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system (English)

1 reference

22 September 2017

Laurent Ramont

1

1 reference

22 September 2017

Sylvie Pasco

2

1 reference

22 September 2017

William Hornebeck

3

1 reference

22 September 2017

François-Xavier Maquart

4

1 reference

22 September 2017

Jean Claude Monboisse

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

Experimental Cell Research

22 September 2017

1 reference

22 September 2017

291

1 reference

22 September 2017

1

1 reference

22 September 2017

1-10

1 reference

Matrix-directed regulation of pericellular proteolysis and tumor progression

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Matrix metalloproteinases in human melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

The plasminogen activation system in tumor growth, invasion, and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

The urokinase-type plasminogen activator system in cancer metastasis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

A cell binding domain from the alpha3 chain of type IV collagen inhibits proliferation of melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

In situ expression of transforming growth factor ?? is associated with melanoma progression and correlates with Ki67, HLA-DR and ?? 3 integrin expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

TGF-?-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Tumor suppressor activity of the TGF-beta pathway in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Contribution of the plasmin/matrix metalloproteinase cascade to the retraction of human fibroblast populated collagen lattices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

The alpha 3(IV)185-206 peptide from noncollagenous domain 1 of type IV collagen interacts with a novel binding site on the beta 3 subunit of integrin alpha Vbeta 3 and stimulates focal adhesion kinase and phosphatidylinositol 3-kinase phosphorylatio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Inhibitory role of plasminogen activator inhibitor-1 in invasion and proliferation of HLE hepatocellular carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Role of the alpha v beta 3 integrin in human melanoma cell invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

The plasminogen activation system in melanoma cell lines and in melanocytic lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900336-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-4827(03)00336-7

1 reference

22 September 2017

1 reference